Research ArticleMetabolism, Transport, and Pharmacogenomics
Organic Anion Transporter 2 mediates hepatic uptake of tolbutamide, a Cytochrome P450 2C9 probe drug
Yi-an Bi, Sumathy Mathialagan, Laurie Tylaska, Myra Fu, Julie Keefer, Anna Vildhede, Chester Costales, A. David Rodrigues and Manthena Varma
Journal of Pharmacology and Experimental Therapeutics January 11, 2018, jpet.117.245951; DOI: https://doi.org/10.1124/jpet.117.245951
Yi-an Bi
Pfizer Inc
Sumathy Mathialagan
Pfizer Inc
Laurie Tylaska
Pfizer Inc
Myra Fu
Pfizer Inc
Julie Keefer
Pfizer Inc
Anna Vildhede
Pfizer Inc
Chester Costales
Pfizer Inc
A. David Rodrigues
Pfizer Inc
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMetabolism, Transport, and Pharmacogenomics
Organic Anion Transporter 2 mediates hepatic uptake of tolbutamide, a Cytochrome P450 2C9 probe drug
Yi-an Bi, Sumathy Mathialagan, Laurie Tylaska, Myra Fu, Julie Keefer, Anna Vildhede, Chester Costales, A. David Rodrigues and Manthena Varma
Journal of Pharmacology and Experimental Therapeutics January 11, 2018, jpet.117.245951; DOI: https://doi.org/10.1124/jpet.117.245951
Research ArticleMetabolism, Transport, and Pharmacogenomics
Organic Anion Transporter 2 mediates hepatic uptake of tolbutamide, a Cytochrome P450 2C9 probe drug
Yi-an Bi, Sumathy Mathialagan, Laurie Tylaska, Myra Fu, Julie Keefer, Anna Vildhede, Chester Costales, A. David Rodrigues and Manthena Varma
Journal of Pharmacology and Experimental Therapeutics January 11, 2018, jpet.117.245951; DOI: https://doi.org/10.1124/jpet.117.245951
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement